CNS relapse of diffuse large B cell Lymphoma A single centre experience

BACKGROUND AND OBJECTIVE: Central nervous system (CNS) relapse of diffuse large B cell lymphoma (DLBCL) is relatively uncommon and nearly fatal. Two years CNS relapse risk is 0.8% in low, 3.9% in intermediate and 12% in high risk patients. Our aim was to study, the baseline characteristics and outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazir, Adil, Fawad, Siddique, Neelam, Hameed, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768843/
https://www.ncbi.nlm.nih.gov/pubmed/29492077
http://dx.doi.org/10.12669/pjms.336.13812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768843/
https://www.ncbi.nlm.nih.gov/pubmed/29492077
http://dx.doi.org/10.12669/pjms.336.13812

Ejemplares similares